Literature DB >> 34860284

Anxiety and cognitive-related effects of Δ 9-tetrahydrocannabinol (THC) are differentially mediated through distinct GSK-3 vs. Akt-mTOR pathways in the nucleus accumbens of male rats.

Roger Hudson1,2, Christopher Norris1,2, Hanna J Szkudlarek1,2, Dinat Khan1,2, Susanne Schmid1,2, Walter J Rushlow1,2,3, Steven R Laviolette4,5,6.   

Abstract

RATIONALE: Δ9-tetrahydrocannabinol (THC) is the primary psychoactive compound in cannabis and is responsible for cannabis-related neuropsychiatric side effects, including abnormal affective processing, cognitive and sensory filtering deficits and memory impairments. A critical neural region linked to the psychotropic effects of THC is the nucleus accumbens shell (NASh), an integrative mesocorticolimbic structure that sends and receives inputs from multiple brain areas known to be dysregulated in various disorders, including schizophrenia and anxiety-related disorders. Considerable evidence demonstrates functional differences between posterior vs. anterior NASh sub-regions in the processing of affective and cognitive behaviours influenced by THC. Nevertheless, the neuroanatomical regions and local molecular pathways responsible for these psychotropic effects are not currently understood.
OBJECTIVES: The objectives of this study were to characterize the effects of intra-accumbens THC in the anterior vs. posterior regions of the NASh during emotional memory formation, sensorimotor gating and anxiety-related behaviours.
METHODS: We performed an integrative series of translational behavioural pharmacological studies examining anxiety, sensorimotor gating and fear-related associative memory formation combined with regionally specific molecular signalling analyses in male Sprague Dawley rats.
RESULTS: We report that THC in the posterior NASh causes distortions in emotional salience attribution, impaired sensory filtering and memory retention and heightened anxiety, through a glycogen-synthase-kinase-3 (GSK-3)-β-catenin dependent signalling pathway. In contrast, THC in the anterior NASh produces anxiolytic effects via modulation of protein kinase B (Akt) phosphorylation states.
CONCLUSIONS: These findings reveal critical new insights into the neuroanatomical and molecular mechanisms associated with the differential neuropsychiatric side effects of THC in dissociable nucleus accumbens sub-regions.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Akt; Anxiety; Cannabinoids; Cognition; GSK-3; Nucleus accumbens; THC

Mesh:

Substances:

Year:  2021        PMID: 34860284     DOI: 10.1007/s00213-021-06029-w

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  62 in total

1.  Exploring anxiety in schizophrenia: New light on a hidden figure.

Authors:  Mariachiara Buonocore; Marta Bosia; Maria Alice Baraldi; Margherita Bechi; Marco Spangaro; Federica Cocchi; Laura Bianchi; Carmelo Guglielmino; Antonella Rita Mastromatteo; Roberto Cavallaro
Journal:  Psychiatry Res       Date:  2018-07-30       Impact factor: 3.222

2.  Orexin in Rostral Hotspot of Nucleus Accumbens Enhances Sucrose 'Liking' and Intake but Scopolamine in Caudal Shell Shifts 'Liking' Toward 'Disgust' and 'Fear'.

Authors:  Daniel C Castro; Rachel A Terry; Kent C Berridge
Journal:  Neuropsychopharmacology       Date:  2016-01-20       Impact factor: 7.853

3.  Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Authors:  Sagnik Bhattacharyya; Paul D Morrison; Paolo Fusar-Poli; Rocio Martin-Santos; Stefan Borgwardt; Toby Winton-Brown; Chiara Nosarti; Colin M O' Carroll; Marc Seal; Paul Allen; Mitul A Mehta; James M Stone; Nigel Tunstall; Vincent Giampietro; Shitij Kapur; Robin M Murray; Antonio W Zuardi; José A Crippa; Zerrin Atakan; Philip K McGuire
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

4.  Cannabinoid transmission in the prelimbic cortex bidirectionally controls opiate reward and aversion signaling through dissociable kappa versus μ-opiate receptor dependent mechanisms.

Authors:  Tasha Ahmad; Nicole M Lauzon; Xavier de Jaeger; Steven R Laviolette
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

5.  Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia.

Authors:  Radhika Chadha; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2020-01-17       Impact factor: 7.853

6.  Sex differences in the risk of schizophrenia: evidence from meta-analysis.

Authors:  Andre Aleman; René S Kahn; Jean-Paul Selten
Journal:  Arch Gen Psychiatry       Date:  2003-06

7.  Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum.

Authors:  Matthijs G Bossong; Mitul A Mehta; Bart N M van Berckel; Oliver D Howes; René S Kahn; Paul R A Stokes
Journal:  Psychopharmacology (Berl)       Date:  2015-03-25       Impact factor: 4.530

8.  Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.

Authors:  Sagnik Bhattacharyya; José Alexandre Crippa; Paul Allen; Rocio Martin-Santos; Stefan Borgwardt; Paolo Fusar-Poli; Katya Rubia; Joseph Kambeitz; Colin O'Carroll; Marc L Seal; Vincent Giampietro; Michael Brammer; Antonio Waldo Zuardi; Zerrin Atakan; Philip K McGuire
Journal:  Arch Gen Psychiatry       Date:  2012-01

9.  Altered cortico-striatal crosstalk underlies object recognition memory deficits in the sub-chronic phencyclidine model of schizophrenia.

Authors:  Aman Asif-Malik; Daniel Dautan; Andrew M J Young; Todor V Gerdjikov
Journal:  Brain Struct Funct       Date:  2017-03-14       Impact factor: 3.270

10.  Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/β-Catenin Signaling Pathway in Peripheral Blood.

Authors:  Chad A Bousman; Stephen J Glatt; Sharon D Chandler; James Lohr; William S Kremen; Ming T Tsuang; Ian P Everall
Journal:  Psychiatry J       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.